Search En menu en ClientConnect
Top 5 search results See all results Advanced search
Top searches
Most visited pages
    Reference: 20160607
    Release date: 13 January 2017

    Promoter – Financial Intermediary




    The proposed operation concerns the financing of Livanova's research and development (R&D) activities in the cardiac surgery and cardiac rhythm management franchises.


    The operation targets the promoter's research, development and innovation (RDI) activities for the development of new products and technologies in the cardiac surgery and cardiac rhythm management sectors. The activities will be carried out in Italy and France in the period 2017 to 2019.


    Proposed EIB finance (Approximate amount)

    EUR 100 million

    Total cost (Approximate amount)

    Not disclosed.

    Environmental aspects

    The project concerns investments in research and development that are expected to be carried out in existing facilities, already authorised, and which would therefore not require an environmental impact assessment (EIA) under Directive 2011/92/EU. Full environmental details will be verified during the appraisal.


    The promoter is a private company not operating in the utilities sector, and is thus not covered by EU directives on procurement.


    Signed - 1/07/2017


    Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
    They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).

    Related tags

    Italy France Industry